DOGLIOTTI, Luigi

DOGLIOTTI, Luigi  

Dip. SCIENZE CLINICHE E BIOLOGICHE (attivo dal 01/01/1900 al 30/04/2013)  

Mostra records
Risultati 1 - 20 di 233 (tempo di esecuzione: 0.035 secondi).
Titolo Data di pubblicazione Autore(i) File
A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer Chronotherapy. 1999 LÉVI F ;ZIDANI R ;BRIENZA S ;DOGLIOTTI L ;PERPOINT B ;ROTARSKI M ;LETOURNEAU Y ;LLORY JF ;CHOLLET P ;LE ROL A ;FOCAN C
A new magnesium-containing PEG-electrolyte solution for the oral lavage of the colon. 1999 CITTADINI G; DE CICCO E; CITTADINI G JR; DE CATA T; L. DOGLIOTTI; ROSSO E
A randomized comparison of high dose epirubicin versus high dose epirubicin plus lonidamine in advanced breast cancer patients. First results from a cooperative group study 1994 Dogliotti L; Berruti A; Buniva T; Zola P; Baù MG; Farris A; Sarobba MG; Bottini A; Alquati P; Deltetto F; Gosso P; Monzeglio C; Moro G; Sussio M; Perroni D.
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. 2001 FIORENTINO C; A. BERRUTI; BOTTINI A; BODINI M; BRIZZI MP; BRUNELLI A; MARINI U; ALLEVI G; AGUGGINI S; TIRA A; ALQUATI P; OLIVETTI L; DOGLIOTTI L
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma 2009 Brizzi MP; Sculli CM; Ragni F; Porpiglia F; Tampellini M; Gorzegno G; Priola AM; Dogliotti L; Berruti A.
[Acute effect of ACTH administered in vivo on the 11-beta-hydroxylase activity of rat adrenal gland homogenates] 1971 LAURO R ;DE MARTINIS C ;DOGLIOTTI L ;FONZO D ;NELSON DH
Acute myeloblastic leukemia associated with mediastinal nonseminomatous germ cell tumors. Report on two cases. 1995 BERRUTI A; PAZE E; FARA E; GORZEGNO G; DOGLIOTTI L
Adenohypophyseal hormone levels in the cerebrospinal fluid of patients with pituitary disease. 1983 DOGLIOTTI L ;FAGGIUOLO R ;ORLANDI F ;PACCOTTI P ;ANGELI A
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC). 2003 DI COSTANZO F.; SOBRERO A.; GASPERONI S.; L. DOGLIOTTI; FRASSINETI L.; FALCONE A.; LIONETTO R.; BRUZZI P.; LUPPI G.; GALLO L.; CONTE P.; COMANDONE A.; TURCI D.; MARZOLA M.; FOLCO U.; PFANNER E.; MESTRINER M.; BONI C.; GALLI C.; TONATO M.; ROSSO R.
Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer 2005 SOBRERO A; FRASSINETI G; FALCONE A; L. DOGLIOTTI; ROSSO R; COSTANZO FD; BRUZZI P
Advanced prostate cancer: at last a role for medical oncologists 2007 L. DOGLIOTTI
Aggiornamenti in Cronochemioterapia 2004 Dogliotti L; Tampellini M; Angeli A
[Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline] 1979 MUSSA A ;SANDRUCCI S ;DOGLIOTTI L
Apocrine cells in breast cyst fluid and their relationship to cyst type: a morphometric study. 1988 BECCATI D ;GRILLI N ;SCHINCAGLIA P ;NALDONI C ;TAVOLAZZI L ;RANALDI R ;DOGLIOTTI L ;TORTA M ;ANGELI A
Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast. 1992 NALDONI C; COSTANTINI M; L. DOGLIOTTI; BRUZZI P; BUCCHI L; BUZZI G; TORTA M; ANGELI A
Background to and management of treatment-related bone loss in prostate cancer. 2002 A. BERRUTI; TUCCI M; TERRONE C; GORZEGNO G; SCARPA RM; ANGELI A; DOGLIOTTI L
Bevacizumab Plus Octreotide and Metronomic Capecitabine in Patients with Metastatic Well-to-Moderately Differentiated Neuroendocrine Tumors. The XELBEVOCT Multicenter Phase II Study 2012 Brizzi MP; Fazio N; Ferrero A; Nobili E; Volante M; Tozzi L; D'Avolio A; Milanesi E; Dogliotti L; Berruti A
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 2014 Berruti A;Fazio N;Ferrero A;Brizzi MP;Volante M;Nobili E;Tozzi L;Bodei L;Torta M;D'Avolio A;Priola AM;Birocco N;Amoroso V;Biasco G;Papotti M;Dogliotti L
Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension. 1996 BERRUTI A.; PIOVESAN A.; TORTA M.; RAUCCI CA.; GORZEGNO G.; PACCOTTI P.; DOGLIOTTI L; ANGELI A.
Biochemical picture of bone metabolism in breast cancer patients with bone metastases. 1995 BERRUTI A; TORTA M; PIOVESAN A; RAUCCI CA; ORLANDI F; PANERO A; L. DOGLIOTTI; ANGELI A